Michael Schell
Concepts (263)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Radiosurgery | 17 | 1994 | 24 |
Why?
| Brachytherapy | 20 | 1985 | 32 |
Why?
| Brain Neoplasms | 9 | 1997 | 116 |
Why?
| Radiotherapy Dosage | 27 | 1979 | 55 |
Why?
| Radiotherapy Planning, Computer-Assisted | 10 | 1987 | 20 |
Why?
| Central Nervous System | 1 | 2011 | 77 |
Why?
| Lung Neoplasms | 7 | 1994 | 159 |
Why?
| Radiotherapy | 5 | 1990 | 73 |
Why?
| Iodine Radioisotopes | 9 | 1985 | 64 |
Why?
| Carcinoma, Squamous Cell | 2 | 1984 | 111 |
Why?
| Radiometry | 5 | 1982 | 31 |
Why?
| Dose Fractionation | 6 | 2001 | 25 |
Why?
| Adenocarcinoma | 1 | 2006 | 167 |
Why?
| Prostatic Neoplasms | 7 | 1985 | 120 |
Why?
| Fast Neutrons | 8 | 1979 | 2 |
Why?
| Stents | 3 | 1999 | 55 |
Why?
| Algorithms | 4 | 1996 | 226 |
Why?
| Beta Particles | 1 | 1999 | 3 |
Why?
| Humans | 56 | 1979 | 1856 |
Why?
| Neutrons | 5 | 1979 | 4 |
Why?
| Coronary Vessels | 2 | 1999 | 53 |
Why?
| Blood Vessels | 1 | 1999 | 65 |
Why?
| Radiotherapy, High-Energy | 6 | 1980 | 16 |
Why?
| Ear Neoplasms | 1 | 1996 | 7 |
Why?
| Professional Staff Committees | 3 | 2001 | 6 |
Why?
| Neurilemmoma | 1 | 1996 | 12 |
Why?
| Radiation Oncology | 3 | 2001 | 11 |
Why?
| Pancreatic Neoplasms | 2 | 1991 | 46 |
Why?
| Particle Accelerators | 5 | 1982 | 9 |
Why?
| Vestibule, Labyrinth | 1 | 1996 | 15 |
Why?
| Pituitary Neoplasms | 1 | 1995 | 25 |
Why?
| Tunica Intima | 3 | 1998 | 31 |
Why?
| Aged, 80 and over | 9 | 2002 | 599 |
Why?
| Research Design | 3 | 2001 | 169 |
Why?
| Male | 28 | 1982 | 1553 |
Why?
| Brain Diseases | 2 | 1990 | 75 |
Why?
| Radiotherapy, Computer-Assisted | 3 | 1987 | 9 |
Why?
| Treatment Outcome | 8 | 2001 | 661 |
Why?
| Feasibility Studies | 4 | 1999 | 144 |
Why?
| Middle Aged | 15 | 1982 | 1161 |
Why?
| Stereotaxic Techniques | 2 | 1990 | 24 |
Why?
| Glioblastoma | 3 | 1982 | 44 |
Why?
| Aged | 14 | 1982 | 988 |
Why?
| Radiation Dosage | 5 | 1979 | 65 |
Why?
| Neoplasms | 4 | 1979 | 239 |
Why?
| Vascular Surgical Procedures | 2 | 2000 | 39 |
Why?
| Neoplasm Metastasis | 2 | 2008 | 112 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2003 | 121 |
Why?
| Treatment Failure | 2 | 2006 | 88 |
Why?
| Thoracic Neoplasms | 1 | 2009 | 16 |
Why?
| Liver Neoplasms | 2 | 2006 | 97 |
Why?
| Mathematics | 2 | 1979 | 75 |
Why?
| Adult | 14 | 1982 | 1317 |
Why?
| Carotid Stenosis | 2 | 1999 | 33 |
Why?
| Monte Carlo Method | 4 | 1987 | 40 |
Why?
| Female | 20 | 1982 | 1643 |
Why?
| Tomography, X-Ray Computed | 5 | 1987 | 321 |
Why?
| Practice Guidelines as Topic | 1 | 2010 | 174 |
Why?
| Survival Analysis | 2 | 2006 | 205 |
Why?
| Muscle, Smooth, Vascular | 2 | 2000 | 59 |
Why?
| Glioma | 1 | 2008 | 51 |
Why?
| Paclitaxel | 2 | 2003 | 37 |
Why?
| Cisplatin | 2 | 2003 | 43 |
Why?
| Antineoplastic Protocols | 1 | 2006 | 3 |
Why?
| Hyperplasia | 6 | 1998 | 55 |
Why?
| Magnetic Resonance Imaging | 4 | 1996 | 294 |
Why?
| Prochlorperazine | 1 | 2005 | 5 |
Why?
| Ondansetron | 1 | 2005 | 6 |
Why?
| Biophysical Phenomena | 4 | 1994 | 30 |
Why?
| Radiotherapy, Conformal | 2 | 2001 | 12 |
Why?
| Dose-Response Relationship, Radiation | 8 | 1980 | 85 |
Why?
| Biophysics | 4 | 1994 | 37 |
Why?
| Antiemetics | 1 | 2005 | 15 |
Why?
| Decision Theory | 3 | 1997 | 5 |
Why?
| Vomiting | 1 | 2005 | 45 |
Why?
| Postoperative Care | 1 | 2004 | 84 |
Why?
| Film Dosimetry | 3 | 1979 | 3 |
Why?
| Dexamethasone | 1 | 2005 | 109 |
Why?
| Palladium | 3 | 1996 | 10 |
Why?
| Balloon Dilation | 3 | 1998 | 42 |
Why?
| Models, Structural | 4 | 1987 | 42 |
Why?
| Nausea | 1 | 2005 | 34 |
Why?
| Ifosfamide | 1 | 2003 | 2 |
Why?
| Photogrammetry | 1 | 2003 | 3 |
Why?
| Radiation Protection | 3 | 1987 | 17 |
Why?
| Immobilization | 1 | 2003 | 27 |
Why?
| Carcinoma, Small Cell | 1 | 2003 | 20 |
Why?
| Peripheral Vascular Diseases | 1 | 2002 | 26 |
Why?
| United States | 4 | 1999 | 604 |
Why?
| Imaging, Three-Dimensional | 1 | 2003 | 58 |
Why?
| Radiation Injuries | 5 | 1984 | 63 |
Why?
| Retrospective Studies | 4 | 2006 | 653 |
Why?
| Blood Vessel Prosthesis Implantation | 1 | 2001 | 24 |
Why?
| Breast Neoplasms | 2 | 2004 | 185 |
Why?
| Image Enhancement | 1 | 2003 | 70 |
Why?
| Carotid Arteries | 2 | 1998 | 51 |
Why?
| Radioisotopes | 2 | 1996 | 28 |
Why?
| Prostatic Diseases | 1 | 2000 | 9 |
Why?
| Computer Simulation | 2 | 1999 | 134 |
Why?
| Cobalt Radioisotopes | 2 | 1979 | 12 |
Why?
| Models, Theoretical | 4 | 1979 | 124 |
Why?
| Models, Biological | 3 | 1990 | 410 |
Why?
| Calibration | 1 | 1999 | 37 |
Why?
| Models, Genetic | 2 | 1996 | 90 |
Why?
| Tantalum | 1 | 1999 | 7 |
Why?
| Intracranial Arteriovenous Malformations | 1 | 1999 | 14 |
Why?
| Alloys | 1 | 1999 | 16 |
Why?
| X-Rays | 1 | 1999 | 20 |
Why?
| Nickel | 1 | 1999 | 21 |
Why?
| Vascular Diseases | 1 | 2000 | 60 |
Why?
| Technology, Radiologic | 1 | 1979 | 13 |
Why?
| Survival Rate | 3 | 2003 | 250 |
Why?
| Energy Transfer | 2 | 1987 | 19 |
Why?
| Graft Occlusion, Vascular | 1 | 1999 | 22 |
Why?
| Ultrasonography, Interventional | 1 | 1999 | 32 |
Why?
| Angioplasty, Balloon, Coronary | 1 | 1999 | 29 |
Why?
| Titanium | 1 | 1999 | 36 |
Why?
| Kaplan-Meier Estimate | 2 | 2008 | 89 |
Why?
| Coronary Artery Disease | 1 | 1999 | 56 |
Why?
| Platelet-Derived Growth Factor | 1 | 1998 | 37 |
Why?
| Pilot Projects | 3 | 1980 | 264 |
Why?
| Prognosis | 4 | 1980 | 388 |
Why?
| Uterine Cervical Neoplasms | 2 | 1987 | 55 |
Why?
| Orbital Neoplasms | 2 | 1985 | 16 |
Why?
| Quality Assurance, Health Care | 1 | 1998 | 83 |
Why?
| Animals | 9 | 1987 | 1031 |
Why?
| Radiographic Image Enhancement | 1 | 1996 | 29 |
Why?
| Image Processing, Computer-Assisted | 1 | 1998 | 138 |
Why?
| Coronary Disease | 1 | 1999 | 94 |
Why?
| Iridium Radioisotopes | 2 | 1989 | 11 |
Why?
| Macrophages | 1 | 1998 | 148 |
Why?
| Radiography | 1 | 1994 | 11 |
Why?
| Neoplasm Staging | 2 | 2003 | 125 |
Why?
| Lymphoma | 2 | 1985 | 96 |
Why?
| Phantoms, Imaging | 3 | 1996 | 41 |
Why?
| Plastics | 3 | 1982 | 11 |
Why?
| Multivariate Analysis | 2 | 2004 | 225 |
Why?
| Rectum | 2 | 1987 | 29 |
Why?
| Lung | 3 | 1987 | 232 |
Why?
| Head and Neck Neoplasms | 1 | 1994 | 47 |
Why?
| Bone Neoplasms | 2 | 1980 | 83 |
Why?
| Spinal Cord | 1 | 1994 | 94 |
Why?
| Cell Survival | 3 | 1987 | 229 |
Why?
| Duodenum | 1 | 1991 | 24 |
Why?
| Connective Tissue | 1 | 1991 | 22 |
Why?
| Quality Control | 2 | 2000 | 54 |
Why?
| Amifostine | 1 | 1991 | 15 |
Why?
| Cholelithiasis | 1 | 1991 | 16 |
Why?
| Electrons | 2 | 1982 | 10 |
Why?
| Bone and Bones | 2 | 1990 | 99 |
Why?
| Organizational Objectives | 2 | 2001 | 26 |
Why?
| Rats, Sprague-Dawley | 3 | 1998 | 257 |
Why?
| Neoplasm Recurrence, Local | 3 | 1980 | 118 |
Why?
| Graphite | 1 | 1990 | 2 |
Why?
| Forecasting | 2 | 2001 | 147 |
Why?
| Combined Modality Therapy | 2 | 1999 | 219 |
Why?
| Intraoperative Period | 2 | 1999 | 43 |
Why?
| Bromodeoxyuridine | 1 | 1989 | 47 |
Why?
| Salvage Therapy | 1 | 2009 | 37 |
Why?
| Equipment Design | 1 | 1990 | 132 |
Why?
| Carotid Artery Injuries | 2 | 1998 | 17 |
Why?
| Radiation-Sensitizing Agents | 1 | 1989 | 29 |
Why?
| Disease-Free Survival | 1 | 2009 | 102 |
Why?
| Necrosis | 3 | 1980 | 82 |
Why?
| Radiochemistry | 1 | 1987 | 6 |
Why?
| Misonidazole | 1 | 1987 | 4 |
Why?
| Nitroimidazoles | 1 | 1987 | 6 |
Why?
| Comorbidity | 1 | 2009 | 190 |
Why?
| Urinary Bladder | 1 | 1987 | 37 |
Why?
| Time Factors | 4 | 1980 | 896 |
Why?
| Disease Progression | 1 | 2009 | 244 |
Why?
| Remission Induction | 1 | 2006 | 64 |
Why?
| Recurrence | 2 | 1998 | 261 |
Why?
| Rats | 3 | 1998 | 530 |
Why?
| Clinical Trials as Topic | 2 | 1999 | 251 |
Why?
| Serotonin Antagonists | 1 | 2005 | 9 |
Why?
| Carboplatin | 1 | 2005 | 16 |
Why?
| Pharyngeal Neoplasms | 1 | 1984 | 6 |
Why?
| Doxorubicin | 1 | 2005 | 60 |
Why?
| Cyclophosphamide | 1 | 2005 | 82 |
Why?
| Mouth Neoplasms | 1 | 1984 | 20 |
Why?
| Robotics | 1 | 2005 | 21 |
Why?
| Subtraction Technique | 1 | 2003 | 13 |
Why?
| Taxoids | 1 | 2003 | 12 |
Why?
| Patient Satisfaction | 1 | 2005 | 120 |
Why?
| Motion | 1 | 2003 | 23 |
Why?
| Prospective Studies | 1 | 2008 | 545 |
Why?
| Anastomosis, Surgical | 1 | 2002 | 45 |
Why?
| Optics and Photonics | 1 | 2003 | 21 |
Why?
| Posture | 1 | 2003 | 68 |
Why?
| Scattering, Radiation | 2 | 1979 | 36 |
Why?
| Double-Blind Method | 1 | 2005 | 274 |
Why?
| Radiation Tolerance | 1 | 2002 | 37 |
Why?
| Evaluation Studies as Topic | 2 | 1980 | 178 |
Why?
| Sheep | 1 | 2001 | 46 |
Why?
| Respiration | 1 | 2002 | 78 |
Why?
| Vascular Patency | 1 | 2001 | 28 |
Why?
| Polytetrafluoroethylene | 1 | 2001 | 23 |
Why?
| Physics | 1 | 2001 | 8 |
Why?
| Physical Phenomena | 1 | 2001 | 8 |
Why?
| Movement | 1 | 2002 | 69 |
Why?
| Decision Making, Computer-Assisted | 1 | 2000 | 6 |
Why?
| Thermoluminescent Dosimetry | 2 | 1989 | 2 |
Why?
| Interprofessional Relations | 1 | 2001 | 58 |
Why?
| Artificial Intelligence | 1 | 2000 | 16 |
Why?
| Sarcoma | 1 | 1980 | 42 |
Why?
| Soft Tissue Neoplasms | 1 | 1980 | 35 |
Why?
| Pubic Bone | 1 | 1999 | 7 |
Why?
| Diagnostic Imaging | 1 | 2001 | 66 |
Why?
| Muscles | 2 | 1990 | 111 |
Why?
| Urethra | 1 | 1999 | 22 |
Why?
| Radiology | 1 | 1999 | 15 |
Why?
| Radiopharmaceuticals | 1 | 1999 | 37 |
Why?
| Cerebral Hemorrhage | 1 | 1999 | 45 |
Why?
| Angioplasty, Balloon | 1 | 2000 | 35 |
Why?
| Arteriosclerosis | 1 | 2000 | 54 |
Why?
| Child, Preschool | 2 | 1991 | 554 |
Why?
| Quality of Life | 1 | 2003 | 188 |
Why?
| Computers | 1 | 1979 | 58 |
Why?
| Risk Factors | 2 | 1991 | 555 |
Why?
| Cranial Irradiation | 1 | 1998 | 8 |
Why?
| Dose-Response Relationship, Drug | 1 | 2001 | 431 |
Why?
| Disease Models, Animal | 1 | 2001 | 349 |
Why?
| Prostate | 1 | 1999 | 55 |
Why?
| Analysis of Variance | 1 | 1999 | 339 |
Why?
| Cell Adhesion | 1 | 1998 | 113 |
Why?
| Probability | 1 | 1997 | 190 |
Why?
| Child | 2 | 1991 | 749 |
Why?
| Observer Variation | 1 | 1996 | 103 |
Why?
| Adolescent | 2 | 1991 | 891 |
Why?
| Cell Movement | 1 | 1998 | 163 |
Why?
| Cell Line | 2 | 1989 | 375 |
Why?
| Cell Division | 1 | 1998 | 273 |
Why?
| Mediastinum | 1 | 1994 | 18 |
Why?
| Photons | 1 | 1994 | 13 |
Why?
| Follow-Up Studies | 1 | 1999 | 553 |
Why?
| Gases | 2 | 1982 | 23 |
Why?
| Urinary Diversion | 1 | 1991 | 4 |
Why?
| Brain | 1 | 1999 | 305 |
Why?
| Parenteral Nutrition | 1 | 1991 | 21 |
Why?
| Ileum | 1 | 1991 | 33 |
Why?
| Cells, Cultured | 2 | 1987 | 447 |
Why?
| Dogs | 1 | 1991 | 159 |
Why?
| Mathematical Computing | 1 | 1990 | 12 |
Why?
| Breast | 1 | 1990 | 40 |
Why?
| Surgical Procedures, Operative | 1 | 1990 | 77 |
Why?
| Interphase | 1 | 1989 | 26 |
Why?
| Etanidazole | 1 | 1987 | 4 |
Why?
| Methods | 1 | 1987 | 133 |
Why?
| Cricetulus | 1 | 1987 | 39 |
Why?
| Cricetinae | 1 | 1987 | 130 |
Why?
| Regression Analysis | 1 | 1987 | 256 |
Why?
| Infant | 1 | 1991 | 464 |
Why?
| Oropharynx | 1 | 1984 | 9 |
Why?
| Neck | 1 | 1984 | 31 |
Why?
| Lymphatic Metastasis | 1 | 1984 | 77 |
Why?
| Gamma Rays | 1 | 1982 | 38 |
Why?
| Magnetics | 1 | 1982 | 30 |
Why?
| Osteoradionecrosis | 1 | 1980 | 3 |
Why?
| Mucous Membrane | 1 | 1980 | 37 |
Why?
| Gastrointestinal Diseases | 1 | 1980 | 31 |
Why?
| Central Nervous System Diseases | 1 | 1980 | 33 |
Why?
| Skin Diseases | 1 | 1980 | 69 |
Why?
|
|
Schell's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
